COVID-19: List of comorbidities that make people above 45 eligible for vaccine shot

As COVID-19 cases surge in in the country after witnessing a decline in numbers for weeks, authorities have commenced the second phase of the vaccination drive in the country on March 1. Prime Minister Narendra Modi, Vice-President M Venkaiah Naidu and a host of other politicians were administered the first dose of the COVID-19 vaccine.

In the second phase, people above 60 years and those aged 45 and above with certain comorbidities are eligible for vaccination. The government expects to reach around 27 crore people who are on the priority list after healthcare and frontline workers.

Eligible people can register for vaccination through the Co-WIN2.0 portal and avail doses from around 10,000 hospitals empanelled under the Ayushman Bharat-PMJAY and 687 hospitals under CGHS that can be used by states as vaccination centres (CVCs). Here's a list of the comorbidities that make you eligible for COVID-19 vaccination under the second phase.

Heart failure with hospital admission in past one year.

Left ventricular assist device in end-stage heart disease.

Left ventricular systolic dysfunction.

Moderate or severe valvular heart disease.

Congenital heart disease with severe pulmonary arterial hypertension.

Coronary artery disease with hypertension or diabetes.

Undergoing treatment for angina (chest pain) with hypertension or diabetes.

Documented stroke case with hypertension or diabetes (on treatment).

Pulmonary artery hypertension and hypertension or diabetes (on treatment).

Diabetes less than 10 years or with complications and hypertension (on treatment).

Those who have undergone heart, kidney, liver or haematopoietic stem cell transplant.

End-stage kidney disease on dialysis.

Those on prolonged use of oral corticosteroids or immunosuppressant medications.

Those with decompensated cirrhosis.

Any respiratory disease including hospitalisation in the past two years.

Lymphoma, leukaemia or myeloma.

Those diagnosed with cancer on or after July 1, 2020, or currently undergoing cancer therapy.

Sickle Cell Disease, bone marrow failure, aplastic anaemia or thalassemia major.

HIV infection, or primary immunodeficiency diseases.

Those with multiple disabilities such as blindness, deafness, acid attack with the involvement of respiratory tract, muscular dystrophy, intellectual disabilities, disabled requiring high support needs.